These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38828562)

  • 21. Biphasic changes in the Ser-9 phosphorylation of glycogen synthase kinase-3beta after electroconvulsive shock in the rat brain.
    Roh MS; Kang UG; Shin SY; Lee YH; Jung HY; Juhnn YS; Kim YS
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):1-5. PubMed ID: 12551719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution and co-localization of choline acetyltransferase and p75 neurotrophin receptors in the sheep basal forebrain: implications for the use of a specific cholinergic immunotoxin.
    Ferreira G; Meurisse M; Tillet Y; Lévy F
    Neuroscience; 2001; 104(2):419-39. PubMed ID: 11377845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffusion-weighted magnetic resonance imaging detection of basal forebrain cholinergic degeneration in a mouse model.
    Kerbler GM; Hamlin AS; Pannek K; Kurniawan ND; Keller MD; Rose SE; Coulson EJ
    Neuroimage; 2013 Feb; 66():133-41. PubMed ID: 23128077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basal forebrain neurons suppress amygdala kindling via cortical but not hippocampal cholinergic projections in rats.
    Ferencz I; Leanza G; Nanobashvili A; Kokaia M; Lindvall O
    Eur J Neurosci; 2000 Jun; 12(6):2107-16. PubMed ID: 10886350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perinatal 192 IgG-Saporin as Neuroteratogen.
    Petrosini L; De Bartolo P; Cutuli D; Gelfo F
    Curr Top Behav Neurosci; 2016; 29():111-123. PubMed ID: 26695170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral and neurobiological alterations induced by the immunotoxin 192-IgG-saporin: cholinergic and non-cholinergic effects following i.c.v. injection.
    Walsh TJ; Kelly RM; Dougherty KD; Stackman RW; Wiley RG; Kutscher CL
    Brain Res; 1995 Dec; 702(1-2):233-45. PubMed ID: 8846082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered NGF protein levels in different brain areas after immunolesion.
    Yu J; Wiley RG; Perez-Polo RJ
    J Neurosci Res; 1996 Jan; 43(2):213-23. PubMed ID: 8820969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 192 IgG-saporin lesion of basal forebrain cholinergic neurons in neonatal rats.
    Pappas BA; Davidson CM; Fortin T; Nallathamby S; Park GA; Mohr E; Wiley RG
    Brain Res Dev Brain Res; 1996 Oct; 96(1-2):52-61. PubMed ID: 8922668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 192IGG-saporin-induced selective lesion of cholinergic basal forebrain system: neurochemical effects on cholinergic neurotransmission in rat cerebral cortex and hippocampus.
    Rossner S; Schliebs R; Härtig W; Bigl V
    Brain Res Bull; 1995; 38(4):371-81. PubMed ID: 8535860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neonatal treatment with 192 IgG-saporin produces long-term forebrain cholinergic deficits and reduces dendritic branching and spine density of neocortical pyramidal neurons.
    Robertson RT; Gallardo KA; Claytor KJ; Ha DH; Ku KH; Yu BP; Lauterborn JC; Wiley RG; Yu J; Gall CM; Leslie FM
    Cereb Cortex; 1998 Mar; 8(2):142-55. PubMed ID: 9542893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of hypocretin-1 in 192-IgG-saporin-lesioned rats.
    Blanco-Centurion CA; Shiromani A; Winston E; Shiromani PJ
    Eur J Neurosci; 2006 Oct; 24(7):2084-8. PubMed ID: 17067305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Septal cholinergic neurons suppress seizure development in hippocampal kindling in rats: comparison with noradrenergic neurons.
    Ferencz I; Leanza G; Nanobashvili A; Kokaia Z; Kokaia M; Lindvall O
    Neuroscience; 2001; 102(4):819-32. PubMed ID: 11182245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 192 immunoglobulin G-saporin produces graded behavioral and biochemical changes accompanying the loss of cholinergic neurons of the basal forebrain and cerebellar Purkinje cells.
    Waite JJ; Chen AD; Wardlow ML; Wiley RG; Lappi DA; Thal LJ
    Neuroscience; 1995 Mar; 65(2):463-76. PubMed ID: 7777161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basal Forebrain Cholinergic Deficits Reduce Glucose Metabolism and Function of Cholinergic and GABAergic Systems in the Cingulate Cortex.
    Jeong DU; Oh JH; Lee JE; Lee J; Cho ZH; Chang JW; Chang WS
    Yonsei Med J; 2016 Jan; 57(1):165-72. PubMed ID: 26632397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pain sensitivity following loss of cholinergic basal forebrain (CBF) neurons in the rat.
    Vierck CJ; Yezierski RP; Wiley RG
    Neuroscience; 2016 Apr; 319():23-34. PubMed ID: 26812034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioural, histological and immunocytochemical consequences following 192 IgG-saporin immunolesions of the basal forebrain cholinergic system.
    Perry T; Hodges H; Gray JA
    Brain Res Bull; 2001 Jan; 54(1):29-48. PubMed ID: 11226712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurotrophic factors rescue basal forebrain cholinergic neurons and improve performance on a spatial learning test.
    Lee YS; Danandeh A; Baratta J; Lin CY; Yu J; Robertson RT
    Exp Neurol; 2013 Nov; 249():178-86. PubMed ID: 24017996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neonatal 192 IgG-saporin lesion of forebrain cholinergic neurons: focus on the life span?
    Pappas BA; Sherren N
    Neurosci Biobehav Rev; 2003 Sep; 27(4):365-76. PubMed ID: 12946689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of neonatal lesions of the basal forebrain cholinergic system by 192 immunoglobulin G-saporin: biochemical, behavioural and morphological characterization.
    Leanza G; Nilsson OG; Nikkhah G; Wiley RG; Björklund A
    Neuroscience; 1996 Sep; 74(1):119-41. PubMed ID: 8843082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
    Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
    Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.